Patent ID: 11913020
Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. A method of increasing chemokine (C-X-C motif) receptor 4 (CXCR4) gene expression in a mesenchymal stem cell as compared to a mesenchymal stem cell cultured in a medium not comprising ethionamide, the method comprising:
culturing mesenchymal stem cells in a medium comprising ethionamide for 72 hours,
wherein the medium increases the expression of the CXCR4 gene in a mesenchymal stem cell compared to a mesenchymal stem cell cultured in the medium not comprising ethionamide, and
wherein the ethionamide is contained in the medium at 100 μM.